Pulmonary Wellness
0 view | +0 today
Follow
Your new post is loading...
Your new post is loading...
Rescooped by Noah Greenspan from Pulmonary Wellness
Scoop.it!

Guideline updates treatments for idiopathic pulmonary fibrosis - #IPF

Guideline updates treatments for idiopathic pulmonary fibrosis - #IPF | Pulmonary Wellness | Scoop.it

Guideline updates treatments for idiopathic pulmonary fibrosis. Unchanged from the 2011 guideline were a conditional recommendation againstN-acetylcysteine monotherapy based on low confidence in effect estimate and a conditional recommendation for antacid therapy based on very low confidence in effect estimate. http://t.co/hshfxk0Tqd


Via Bill Vick, Noah Greenspan
more...
Bill Vick's curator insight, July 21, 2015 9:22 AM

The following recommendations are new or revised from the previous guideline:

a strong recommendation against the use of warfarin (low confidence in effect estimates); imatinib (moderate confidence in effect estimates); combination prednisone, azathioprine, and N-acetylcysteine (low confidence in effect estimates); and the selective endothelin receptor antagonist ambrisentan (low confidence in effect estimates),a conditional recommendation for the use of nintedanib (moderate confidence in effect estimates) and pirfenidone (moderate confidence in effect estimates), anda conditional recommendation against the use of the phosphodiesterase-5 inhibitor sildenafil (moderate confidence in effect estimates) or the dual endothelin receptor antagonists macitentan and bosentan (low confidence in effect estimates).
Rescooped by Noah Greenspan from Pulmonary Fibrosis News
Scoop.it!

Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis.

Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis. | Pulmonary Wellness | Scoop.it

This study sought to evaluate the long-term effects of a 12-week ET program on clinical outcomes in IPF patients.


Via Bill Vick
more...
Bill Vick's curator insight, July 26, 2015 10:32 AM

The bottom line of an Exercise Training program in effecting the outcome of #IPF according to a NIH sponsored trial is " We suggest including ET as a long-term continued treatment and as a core component of pulmonary rehabilitation programs for IPF patients."


In other words move, move, move...

Rescooped by Noah Greenspan from Pulmonary Fibrosis News
Scoop.it!

Guideline updates treatments for idiopathic pulmonary fibrosis - #IPF

Guideline updates treatments for idiopathic pulmonary fibrosis - #IPF | Pulmonary Wellness | Scoop.it

Guideline updates treatments for idiopathic pulmonary fibrosis. Unchanged from the 2011 guideline were a conditional recommendation againstN-acetylcysteine monotherapy based on low confidence in effect estimate and a conditional recommendation for antacid therapy based on very low confidence in effect estimate. http://t.co/hshfxk0Tqd


Via Bill Vick
more...
Bill Vick's curator insight, July 21, 2015 9:22 AM

The following recommendations are new or revised from the previous guideline:

a strong recommendation against the use of warfarin (low confidence in effect estimates); imatinib (moderate confidence in effect estimates); combination prednisone, azathioprine, and N-acetylcysteine (low confidence in effect estimates); and the selective endothelin receptor antagonist ambrisentan (low confidence in effect estimates),a conditional recommendation for the use of nintedanib (moderate confidence in effect estimates) and pirfenidone (moderate confidence in effect estimates), anda conditional recommendation against the use of the phosphodiesterase-5 inhibitor sildenafil (moderate confidence in effect estimates) or the dual endothelin receptor antagonists macitentan and bosentan (low confidence in effect estimates).
Rescooped by Noah Greenspan from Pulmonary Fibrosis News
Scoop.it!

Action for Pulmonary Fibrosis UK » Idiopathic Pulmonary Fibrosis webinar

Action for Pulmonary Fibrosis UK » Idiopathic Pulmonary Fibrosis webinar | Pulmonary Wellness | Scoop.it
Idiopathic Pulmonary Fibrosis webinar - I saw this on Action for Pulmonary Fibrosis. #pulmonaryfibrosis http://t.co/tpFoKFFvFC

Via Bill Vick
more...
Bill Vick's curator insight, November 22, 2014 9:25 AM
Idiopathic Pulmonary Fibrosis webinar (UK) Dr Helen Parfrey gave a Webinar during IPF World Week.

Dr Parfrey is a Consultant Respiratory Physician at Papworth Hospital and an interstitial lung disease expert and presented this webinar for the British Lung Foundation.